Cooperative Drug Development Group (CDDG) for the Treatment of Mental Illness

The summary for the Cooperative Drug Development Group (CDDG) for the Treatment of Mental Illness grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cooperative Drug Development Group (CDDG) for the Treatment of Mental Illness: The National Institute of Mental Health (NIMH) requests research grant applications from academic and pharmaceutical/biotechnology industry investigators interested in participating with the National Institute of Mental Health (NIMH) in a Cooperative Drug Development Group (CDDG) program. The goal of the CDDG is to support proof-of-concept studies of novel mechanism drug candidates and promising investigational new drugs (IND) for the treatment of mental disorders. Approximately 1.5 million dollars will be set-aside for this initiative in this first year. One to 3 awards to responsive applications are anticipated on an annual basis. This PA will use the NIH U01 or U19 Cooperative agreement award mechanism. The CDDG is most appropriate for applications that include collaborations, Research Projects or core components from academia and the private sector (e.g., pharmaceutical, chemical, or biotechnological companies). Applications are allowed from single! institutions with agreements for collaboration with other institutions for the performance of specified study components. For-profit or non-profit organizations, public or private institutions are eligible to apply. Foreign institutions are not eligible to apply for this PA but can participate as a subcontract. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Applicants may submit only one application in response to this PA. However, subcontract or consortium partners may be listed as collaborators on more than one application. Application materials are available at http://grants.nih.gov/grants/funding/phs398/phs398.html. Applicants are encouraged to contact program staff listed on the PA prior to submitting an application.
Federal Grant Title: Cooperative Drug Development Group (CDDG) for the Treatment of Mental Illness
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-05-010
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Nov 03, 2004
Creation Date: Nov 03, 2004
Archive Date: May 15, 2007
Total Program Funding: $1,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 1
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply. Scientists from foreign institutions and NIH Intramural laboratories may participate as Project Leaders or as collaborators in Research Project or scientific cores
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 ...
Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 ...
Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com